Arrigoni-Martelli E, Nielsen C K, Olsen U B, Petersen H J
Experientia. 1980 Apr 15;36(4):445-7. doi: 10.1007/BF01975139.
N''-cyano-N-4-pyridyl-N'-1,2,2-trimethylpropylguanidine, monohydrate (P 1134) is a new agent which induces a marked and sustained hypotensive response in normotensive and renal, neurogenic, and spontaneously hypertensive rats, as well as in normotensive and renal hypertensive dogs. The overall potency of this compound is 2-3 times greater than that of hydralazine. The fall of blood pressure is accompanied by an increase in heart rate and cardiac output and a decrease in total peripheral resistance. The hypotensive effect appears to be due primarily to a direct relaxant effect on vascular smooth muscle.
N''-氰基-N-4-吡啶基-N'-1,2,2-三甲基丙基胍一水合物(P 1134)是一种新型药物,在正常血压以及肾性、神经源性和自发性高血压大鼠,以及正常血压和肾性高血压犬中均可引起显著且持续的降压反应。该化合物的总体效力比肼屈嗪高2至3倍。血压下降伴随着心率和心输出量增加以及总外周阻力降低。其降压作用似乎主要归因于对血管平滑肌的直接舒张作用。